{
"NDC": {
"NDCCode": "69097-641-03",
"PackageDescription": "60 CAPSULE in 1 BOTTLE (69097-641-03) ",
"NDC11Code": "69097-0641-03",
"ProductNDC": "69097-641",
"ProductTypeName": "HUMAN PRESCRIPTION DRUG",
"ProprietaryName": "Nintedanib",
"ProprietaryNameSuffix": null,
"NonProprietaryName": "Nintedanib",
"DosageFormName": "CAPSULE",
"RouteName": "ORAL",
"StartMarketingDate": "20260402",
"EndMarketingDate": null,
"MarketingCategoryName": "ANDA",
"ApplicationNumber": "ANDA212609",
"LabelerName": "Cipla USA Inc.",
"SubstanceName": "NINTEDANIB ESYLATE",
"StrengthNumber": "100",
"StrengthUnit": "mg/1",
"Pharm_Classes": "Kinase Inhibitor [EPC], Protein Kinase Inhibitors [MoA]",
"DEASchedule": null,
"Status": "Active",
"LastUpdate": "2026-04-06",
"PackageNdcExcludeFlag": "N",
"ProductNdcExcludeFlag": "N",
"ListingRecordCertifiedThrough": "20271231",
"StartMarketingDatePackage": "20260402",
"EndMarketingDatePackage": null,
"SamplePackage": "N"
}
}